Cannabis medicine is about to move beyond today’s trial-and-error approach toward more personalized, precise treatments
Cannabis medicine is about to move beyond today’s trial-and-error approach toward more personalized, precise treatments
Discussions on the overlooked potential of these powerful compounds are on the rise
Inside the minds of New Jersey’s top cultivators
Tissue culture is emerging as a critical tool in modern cultivation, enabling breeders and cultivators to advance disease-free genetics, consistency, cost efficiency, and scalable production.
Whats normal in other agricultural sectors is coming to cannabis.
Research reveals that chromatin accessibility, not just DNA, plays a significant role in boosting cannabinoid and flavonoid production.
It’s not as far out as you think.
Every cultivar carries its own blueprint, a genetic code that dictates how cannabinoids and terpenes develop, how the plant responds to stress, and what kind of experience it ultimately delivers.